Cancer researcher has dodged accusations for decades (and has a new correction)

Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU).

The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been many more.

The story mentions a 2013 letter from Ohio State University to pseudonymous whistleblower Clare Francis (which we reported on in 2014), acknowledging Francis’s allegations against Croce. However, in the letter, an administrator said OSU saw no reason to investigate Croce.

The story didn’t stop there, as the Times reports:

Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)

Author says he lied about approval for animal research

A researcher in South Korea has retracted a 2015 paper after telling the journal he falsified the institutional approval required to conduct the animal experiments.

In the article, the author explicitly says that the Animal Experiment Review Board of a university based in Seoul, South Korea approved the experiments, but according to the journal, “the author did not receive an approval by the board and he used a false approval number.”

Here’s the retraction notice for “The role of compensatory movements patterns in spontaneous recovery after stroke,” published in the Journal of Physical Therapy Science (JPTS) in September 2015 and retracted in December: Continue reading Author says he lied about approval for animal research

3rd retraction appears for fired Pfizer breast cancer researcher

Pfizer has retracted a paper by a former employee who was fired after the company discovered she had been doctoring data.

The retraction, in Molecular Cancer Research, is the third of five papers Pfizer asked to retract, after an investigation discovered they contained duplicated images. The papers have been discussed on PubPeer, which is also mentioned in the latest retraction notice.

As a result of the investigation, Pfizer terminated the employment of Min-Jean Yin, the last author on the newly retracted paper.

According to the notice, Yin and five of her co-authors agreed to the retraction:

Continue reading 3rd retraction appears for fired Pfizer breast cancer researcher

Researcher who lost whistleblower lawsuit logs 4 more retractions

A brain journal has retracted four papers by a researcher due to image duplications that the university uncovered during an investigation into his work.

According to the retraction notice, Wayne State University found that Christian Kreipke had used several images in these articles “to represent different results in grant proposals and/or poster presentations,” and that the data were unreliable. Kreipke now has a total of five retractions, by our count.

As we’ve reported before, Wayne State and Kreipke have been engaged in conflict for several years. In 2012, Kreipke was dismissed from his assistant professor post at Wayne State after the university said it found evidence of research misconduct, according to Courthouse News. Kreipke fired back against the university, filing a whistleblower lawsuit. In it, Kreipke claimed that the institution was “involved in a conspiracy,” according to unsealed court documents, in which it had swindled the U.S. government out of millions in research funding.

A judge dismissed the case in 2014, but the conflict between Kreipke and Wayne State was not over. Continue reading Researcher who lost whistleblower lawsuit logs 4 more retractions

Unexplained abnormalities in stem cells prompt Columbia researchers to pull diabetes paper

Researchers at Columbia University have retracted a 2013 paper in The Journal of Clinical Investigation, after uncovering abnormalities in the stem cell lines that undermined the conclusions in the paper.

Last year, corresponding author Dieter Egli discovered he could not reproduce key data in the 2013 paper because almost all the cell lines first author Haiqing Hua used contained abnormalities, casting doubt on the overall findings. When Egli reached out to Hua for answers, Hua could not explain the abnormalities. As a result, Hua and Egli agreed the paper should be retracted.

Since some of the details of how the paper ended up relying on abnormal cells remain unclear, the university confirmed to us that it is investigating the matter.

Here’s the retraction notice for “iPSC-derived β cells model diabetes due to glucokinase deficiency,” cited 42 times: Continue reading Unexplained abnormalities in stem cells prompt Columbia researchers to pull diabetes paper

Neuroscientist flags errors in his days-old paper “for the sake of science integrity”

Only days after his paper was published online, a neuroscientist has posted a comment on PubMed alerting readers to several duplication errors.

Despite the issues, which the researcher says were introduced into the final manuscript after peer review, he reassured readers that they do not influence the final conclusions in the paper.

On February 9, ten days after the article came online, corresponding author Garret Stuber at the University of North Carolina at Chapel Hill wrote a detailed comment on PubMed Commons, explaining that the “research community” had brought four figure-related errors to his attention. After investigating the concerns, Stuber discovered that the problems emerged after the peer-review process, “while revising the manuscript to comply with Nature Neuroscience’s final formatting guidelines.” In his note, he outlined the specific duplication issues that arose, which he says he plans to detail to the journal in a formal corrigendum letter.

Stuber alerted the scientific community about his PubMed comment via Twitter: Continue reading Neuroscientist flags errors in his days-old paper “for the sake of science integrity”

Former postdoc admitted to fraud in cell bio paper, lead author says

A researcher in Switzerland has retracted her 2015 paper in the Journal of Cell Biology, saying the first author — her former postdoc — admitted to fabricating multiple aspects of the paper.

After Sophie Martin of the University of Lausanne couldn’t reproduce the data from another manuscript she was preparing to submit, she contacted her former student, Pranav Ullal, who admitted he had fabricated the data, along with two figures in the JCB paper.

A spokesperson for the University of Lausanne told us that Ullal left Switzerland after his contract was over, and is now in India.

Martin told us the whole experience has been upsetting:

Continue reading Former postdoc admitted to fraud in cell bio paper, lead author says

Unusual: Neurology removes author dinged for misconduct from 2016 paper

Neurology has partially retracted a 2016 paper, replacing a figure and removing the author who contributed it after he was found guilty of misconduct.

The journal has replaced the figure with a new one that confirmed the findings of the original, and swapped the name of Andrew Cullinane with the scientist who constructed the new figure using a new dataset. Last year, the U.S. Office of Research Integrity declared that Cullinane had falsified data in this paper and one other while working as a postdoctoral fellow in the Medical Genetics Branch at the National Human Genome Research Institute (NHGRI).

Cullinane appears to be at Howard University in Washington D.C., according to his LinkedIn page. He is listed as an assistant professor in the Basic Sciences/Anatomy department of the university’s College of Medicine.

Here’s the partial retraction notice from the journal:

Continue reading Unusual: Neurology removes author dinged for misconduct from 2016 paper

Cancer biologist stops research as his retraction count rises to 13

Anil Jaiswal

A cancer biologist based at the University of Maryland is transitioning out of research, as a journal has retracted three more of his papers.

Anil Jaiswal has now lost 13 papers, including, as we reported on February 6, six retractions issued earlier this month.

The Baltimore Sun reported this week that Jaiswal would no longer be conducting research at the University of Maryland School of Medicine, which we confirmed from a spokesperson:

Continue reading Cancer biologist stops research as his retraction count rises to 13

Researcher issues massive changes to papers amidst plagiarism investigation

A researcher in Greece has issued extensive — what we sometimes call “mega” — corrections to two 2016 papers published in a medical journal in Romania.

The first author — Alexandra Kalogeraki, a pathology researcher at the University of Crete in Greece — retracted two reviews from the same journal last year for plagiarism. The newest notices remove authors and correct, add, or remove text, often without providing an explicit reason for the change.

The journal told us Kalogeraki initially asked to retract the newly corrected papers, but the editors didn’t believe that the papers warranted the harsher measure, as they’d run a plagiarism scan and conducted peer review of the two papers and did not find any issues. However, the University of Crete is currently investigating allegations of plagiarism in two of Kalogeraki’s other papers, which have already been retracted by the same journal.

For the latest mega-corrections, both are so lengthy we’re only including a small portion of the notice for the case study, “Recurrent Cerebellar Desmoplastic/ Nodular Medulloblastoma in Cerebrospinal Fluid (CSF) in the elderly. A Cytologic Diagnosis,” which deals with authorship: Continue reading Researcher issues massive changes to papers amidst plagiarism investigation